tiprankstipranks
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market

Appili Therapeutics Inc Class A (APLIF) Financial Statements

82 Followers

Appili Therapeutics Inc Class A Financial Overview

Appili Therapeutics Inc Class A's market cap is currently $1.40M. The company's EPS TTM is $-0.0335; its P/E ratio is -0.44; Appili Therapeutics Inc Class A is scheduled to report earnings on June 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 244.18KC$ 100.44KC$ 827.41KC$ 334.18KC$ 1.39M
Gross ProfitC$ 236.09KC$ 100.44KC$ 827.41KC$ 327.91KC$ 1.39M
Operating IncomeC$ -6.53MC$ -190.84KC$ -2.16MC$ -7.91MC$ -24.68M
EBITDAC$ -6.53MC$ 360.57KC$ -2.07MC$ -8.10MC$ -23.51M
Net IncomeC$ -4.24MC$ -2.62MC$ -3.78MC$ -9.24MC$ -25.12M
Balance Sheet
Cash & Short-Term InvestmentsC$ 40.00KC$ 1.23MC$ 94.49KC$ 2.47MC$ 6.66M
Total AssetsC$ 1.97MC$ 3.03MC$ 1.49MC$ 3.13MC$ 8.28M
Total DebtC$ 12.94MC$ 12.29MC$ 8.18MC$ 7.67MC$ 4.98M
Net DebtC$ 12.90MC$ 11.07MC$ 8.09MC$ 5.20MC$ -1.69M
Total LiabilitiesC$ 19.30MC$ 16.43MC$ 12.42MC$ 10.53MC$ 11.55M
Stockholders' EquityC$ -17.33MC$ -13.40MC$ -10.92MC$ -7.40MC$ -3.27M
Cash Flow
Free Cash FlowC$ -1.38MC$ 866.46KC$ -2.49MC$ -10.10MC$ -19.08M
Operating Cash FlowC$ -1.38MC$ 868.82KC$ -2.46MC$ -10.10MC$ -19.08M
Investing Cash FlowC$ 0.00C$ -2.36KC$ -29.06KC$ -3.17KC$ 5.06M
Financing Cash FlowC$ 197.82KC$ 193.68KC$ 122.05KC$ 5.91MC$ 9.56M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Appili Therapeutics Inc Class A Debt to Assets

Appili Therapeutics Inc Class A Cash Flow

Appili Therapeutics Inc Class A Forecast EPS vs Actual EPS